Shanghai HeartCare Medical Technology Corporation (6609) Stock Overview

Shanghai HeartCare Medical Technology Corporation Limited develops, manufacture, and sells neuro-interventional medical devices. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, flow diverter, and vascular access devices, as well as neurovascular stenosis treatment, hemorrhagic stroke treatment, and interventional access. Its products are used for the treatment and prevention of acute ischemic stroke, neurovascular stenosis, and hemorrhagic stroke. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.